{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:26:49Z","timestamp":1789712809239,"version":"4.0.1"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T00:00:00Z","timestamp":1266278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Among HIV\u2010infected patients, hepatitis C virus (HCV) coinfection is associated with lower cholesterol levels, but it remains unclear how it affects cardiovascular outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed logistic regression to evaluate acute myocardial infarction (AMI) and cerebrovascular disease (CVD) events by HCV status among HIV\u2010infected US veterans in the highly active antiretroviral therapy (HAART) era (1996\u20132004). We then performed survival analyses to evaluate incident AMI and CVD, exploring antiretroviral therapy (ART) as a time\u2010dependent variable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 19\u2003424 HIV\u2010infected patients [31.6% of whom were HCV\u2010coinfected (HIV\/HCV)] contributed 76\u2003376 patient\u2010years of follow\u2010up. HCV coinfection was associated with lower rates of hypercholesterolaemia (18.0% in HIV\/HCV <jats:italic>vs<\/jats:italic>. 30.7% in HIV\u2010only patients; <jats:italic>P<\/jats:italic>&lt;0.001), but higher rates of hypertension (43.8%<jats:italic>vs<\/jats:italic>. 35.6%; <jats:italic>P<\/jats:italic>&lt;0.0001), type 2 diabetes mellitus (16.2%<jats:italic>vs<\/jats:italic>. 11.1%; <jats:italic>P<\/jats:italic>&lt;0.0001) and smoking (36.7%<jats:italic>vs<\/jats:italic>. 24.7%; <jats:italic>P<\/jats:italic>=0.009). Rates of AMI and CVD were significantly higher among HIV\/HCV than HIV\u2010only patients: 4.19 <jats:italic>vs<\/jats:italic>. 3.36 events\/1000 patient\u2010years, respectively (<jats:italic>P<\/jats:italic>&lt;0.001), for AMI; and 12.47 <jats:italic>vs<\/jats:italic>. 11.12 events\/1000 patient\u2010years, respectively (<jats:italic>P<\/jats:italic>&lt;0.001), for CVD. When analyses were controlled for diabetes mellitus, hypertension, age and duration of ART, hazard ratios (HRs) among those with HIV\/HCV (<jats:italic>vs<\/jats:italic>. HIV only) were 1.25 [95% confidence interval (CI) 0.98\u20131.61; <jats:italic>P<\/jats:italic>=0.072] for AMI and 1.20 (CI 1.04\u20131.38; <jats:italic>P<\/jats:italic>=0.013) for CVD. Hypertension (HR 2.05; <jats:italic>P<\/jats:italic>&lt;0.001), greater age (HR 1.79; <jats:italic>P<\/jats:italic>&lt;0.001) and longer duration (cumulative years) of antiretroviral use (HR 1.12; <jats:italic>P<\/jats:italic>=0.0411) were also associated with increased risk of AMI in the adjusted model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In the HAART era, HCV coinfection was associated with a significantly increased risk of CVD and a trend towards an increased risk of AMI among HIV\u2010infected patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2009.00815.x","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T03:55:08Z","timestamp":1266378908000},"page":"462-468","source":"Crossref","is-referenced-by-count":102,"title":["Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV\u2010infected patients"],"prefix":"10.1111","volume":"11","author":[{"given":"R","family":"Bedimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A O","family":"Westfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mugavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Saag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,2]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"397","article-title":"Causes of death among persons with AIDS in the era of highly active antiretroviral therapy","volume":"145","author":"Sackoff JE","year":"2006","journal-title":"New York city"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00271.x"},{"key":"e_1_2_6_4_2","first-page":"121","article-title":"Causes of death among human immunodeficiency virus (HIV)\u2010infected adults in the era of potent antiretroviral therapy","volume":"34","author":"Lewden C","year":"2005","journal-title":"emerging role of hepatitis and cancers, persistent role of AIDS"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410802"},{"key":"e_1_2_6_6_2","first-page":"831","article-title":"Hepatitis C virus prevalence among patients infected with human immunodeficiency virus","volume":"34","author":"Sherman KE","year":"2002","journal-title":"a cross-sectional analysis of the US adult AIDS clinical trials group"},{"key":"e_1_2_6_7_2","first-page":"5005","article-title":"Hepatocellular carcinoma and non\u2010Hodgkin's lymphoma","volume":"24","author":"McGinnis KA","year":"2006","journal-title":"the roles of HIV, hepatitis C infection, and alcohol abuse"},{"key":"e_1_2_6_8_2","first-page":"1313","article-title":"Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group","volume":"36","author":"Tedaldi EM","year":"2003","journal-title":"the Terry Beirn community programs for clinical research on AIDS"},{"key":"e_1_2_6_9_2","first-page":"562","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection","volume":"33","author":"Graham CS","year":"2001","journal-title":"a meta-analysis"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-006-0064-y"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200303010-00018"},{"key":"e_1_2_6_12_2","first-page":"145","article-title":"Hepatitis C as a metabolic disease","volume":"33","author":"Koike K.","year":"2005","journal-title":"implication for the pathogenesis of NASH"},{"key":"e_1_2_6_13_2","first-page":"320","article-title":"Hepatitis C, metabolic syndrome, and inflammatory markers","volume":"75","author":"Shaheen M","year":"2007","journal-title":"results from the third national health and nutrition examination survey [NHANES III]"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00126334-200107010-00005","article-title":"Association between insulin resistance and hepatitis C virus chronic infection in HIV\u2010hepatitis C virus\u2010coinfected patients undergoing antiretroviral therapy","volume":"27","author":"Duong M","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_15_2","unstructured":"WeberR SabinCA ReissPet al. Hepatitis Virus Co\u2010infections and Risk of Diabetes Mellitus and Myocardial Infarction in HIV\u2010infected Persons: The D:A:D Study.15th Conference on Retroviruses and Opportunistic Infections. Boston MA February 2008 [Abstract 1082]."},{"key":"e_1_2_6_16_2","first-page":"927","article-title":"Hyperlipidemia in HIV\u2010infected patients","volume":"17","author":"Collazos J","year":"2003","journal-title":"the protective effect of hepatitis C virus co-infection"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00015"},{"key":"e_1_2_6_18_2","first-page":"451","article-title":"Effect of highly active antiretroviral therapy (HAART) and hepatitis C co\u2010infection on hyperlipidemia in HIV\u2010infected patients","volume":"3","author":"Patroni A","year":"2002","journal-title":"a retrospective longitudinal study"},{"key":"e_1_2_6_19_2","first-page":"79","article-title":"Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV\u2010infected patients","volume":"6","author":"Richter A","year":"2005","journal-title":"a retrospective cohort study"},{"key":"e_1_2_6_20_2","first-page":"800","article-title":"Lipid disorders in antiretroviral\u2010naive patients treated with lopinavir\/ritonavir\u2010based HAART","volume":"55","author":"Montes ML","year":"2005","journal-title":"frequency, characterization and risk factors"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2004.00202.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00416.x"},{"key":"e_1_2_6_23_2","first-page":"56","article-title":"Serum lipid pattern in chronic hepatitis C","volume":"13","author":"Siagris D","year":"2006","journal-title":"histological and virological correlations"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani C","year":"1997","journal-title":"Arch Inter Med"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.0150"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh024"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000251503.35795.4f"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-006-0090-6"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.01.010"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280118a0d"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00442-5"},{"key":"e_1_2_6_32_2","first-page":"2349","article-title":"Cirrhosis and hepatocellular carcinoma in HIV\u2010infected veterans with and without the hepatitis C virus","volume":"164","author":"Giordano TP","year":"2004","journal-title":"a cohort study, 1992\u20132001"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070736"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/507031"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/599371"},{"key":"e_1_2_6_36_2","unstructured":"ButtA XiaoqiangW BudoffM.Hepatitis C Virus Infection and the Risk of Coronary Disease.48th International Conference on Antimicrobial Agents and Chemotherapy. Washington DC 2008 [Abstract V\u20104219]."},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.018937"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07339-7"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1326"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2009.00815.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2009.00815.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:17:02Z","timestamp":1698632222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2009.00815.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,2]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1468-1293.2009.00815.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00815.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,2]]}}}